JP2025505933A5 - - Google Patents
Info
- Publication number
- JP2025505933A5 JP2025505933A5 JP2024540577A JP2024540577A JP2025505933A5 JP 2025505933 A5 JP2025505933 A5 JP 2025505933A5 JP 2024540577 A JP2024540577 A JP 2024540577A JP 2024540577 A JP2024540577 A JP 2024540577A JP 2025505933 A5 JP2025505933 A5 JP 2025505933A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence shown
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210011545 | 2022-01-06 | ||
| CN202210011545.7 | 2022-01-06 | ||
| CN202210018557.2 | 2022-01-07 | ||
| CN202210018557 | 2022-01-07 | ||
| PCT/CN2023/070928 WO2023131276A1 (zh) | 2022-01-06 | 2023-01-06 | 靶向msln的抗原结合蛋白及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505933A JP2025505933A (ja) | 2025-03-05 |
| JP2025505933A5 true JP2025505933A5 (https=) | 2026-01-06 |
Family
ID=87073247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540577A Pending JP2025505933A (ja) | 2022-01-06 | 2023-01-06 | Ｍｓｌｎを標的とする抗原結合タンパク質及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250213691A1 (https=) |
| EP (1) | EP4461747A4 (https=) |
| JP (1) | JP2025505933A (https=) |
| CN (1) | CN118510809A (https=) |
| WO (1) | WO2023131276A1 (https=) |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104955845B (zh) * | 2012-09-27 | 2018-11-16 | 美国政府(由卫生和人类服务部的部长所代表) | 间皮素抗体和引起有效的抗肿瘤活性的方法 |
| CN103819559B (zh) * | 2013-12-10 | 2016-02-24 | 中国科学院武汉病毒研究所 | 一种抗间皮素纳米抗体及其编码基因和该纳米抗体的用途 |
| US20170267755A1 (en) * | 2016-03-16 | 2017-09-21 | Sri International | Isolated anti-mesothelin antibodies, conjugates and uses thereof |
| US20180002439A1 (en) * | 2016-06-30 | 2018-01-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anti-mesothelin antibodies and uses thereof |
| CN107840891A (zh) * | 2016-09-19 | 2018-03-27 | 上海吉倍生物技术有限公司 | 高亲和力的抗msln抗体及其应用 |
| EP3621994A4 (en) * | 2017-05-12 | 2020-12-30 | Harpoon Therapeutics, Inc. | MESOTHELIN BINDING PROTEINS |
| WO2019043026A1 (en) * | 2017-08-30 | 2019-03-07 | INSERM (Institut National de la Santé et de la Recherche Médicale) | ANTI-MESOTHELIC RADIOMARQUATED SINGLE DOMAIN ANTIBODIES SUITABLE FOR IMAGING AND TREATING CANCERS |
| KR101966362B1 (ko) * | 2017-10-20 | 2019-04-05 | 주식회사 녹십자 | 항-msln 항체 및 이를 포함하는 암 치료용 약학적 조성물 |
| CN108129566B (zh) * | 2017-12-31 | 2021-05-11 | 中国科学院武汉病毒研究所 | 靶向间皮素的c-型单域抗体及其制备方法与应用 |
| WO2019184886A1 (zh) * | 2018-03-26 | 2019-10-03 | 上海原能细胞医学技术有限公司 | 促进免疫细胞增殖的方法 |
| EP3806889A4 (en) * | 2018-06-18 | 2022-07-13 | Anwita Biosciences, Inc. | CYTOKI FUSION PROTEINS AND USES THEREOF |
| CA3111087A1 (en) * | 2018-08-29 | 2020-03-05 | Nanjing Legend Biotech Co., Ltd. | Anti-mesothelin chimeric antigen receptor (car) constructs and uses thereof |
| CN109111528B (zh) * | 2018-09-20 | 2021-06-22 | 杭州普略生物科技有限公司 | 以msln为靶点的嵌合抗原受体 |
| CA3125484A1 (en) * | 2019-01-08 | 2020-07-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cross-species single domain antibodies targeting mesothelin for treating solid tumors |
| CN110698562B (zh) * | 2019-10-31 | 2022-10-25 | 浙江蓝盾药业有限公司 | 抗人msln单克隆抗体 |
| CN111349165B (zh) * | 2020-05-25 | 2020-09-01 | 南京蓝盾生物科技有限公司 | 抗人msln单克隆抗体及其应用 |
| CN112210008A (zh) * | 2020-07-16 | 2021-01-12 | 上海恒润达生生物科技有限公司 | 一种新型抗人msln抗体及其用途 |
| CN111560072B (zh) * | 2020-07-16 | 2020-12-11 | 上海恒润达生生物科技有限公司 | 抗人msln抗体以及靶向msln的免疫效应细胞 |
| CN112225811A (zh) * | 2020-07-16 | 2021-01-15 | 上海恒润达生生物科技有限公司 | 新型抗人msln抗体及其用途 |
| CN111848819A (zh) * | 2020-07-31 | 2020-10-30 | 广东昭泰体内生物医药科技有限公司 | 一种靶向msln的嵌合抗原受体及其应用 |
| CN118510890A (zh) * | 2022-01-07 | 2024-08-16 | 原启生物科技(上海)有限责任公司 | 靶向cldn18.2和msln的嵌合抗原受体及其用途 |
-
2023
- 2023-01-06 JP JP2024540577A patent/JP2025505933A/ja active Pending
- 2023-01-06 US US18/726,241 patent/US20250213691A1/en active Pending
- 2023-01-06 WO PCT/CN2023/070928 patent/WO2023131276A1/zh not_active Ceased
- 2023-01-06 EP EP23737138.0A patent/EP4461747A4/en active Pending
- 2023-01-06 CN CN202380015977.8A patent/CN118510809A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025028239A5 (https=) | ||
| JP2021094037A5 (https=) | ||
| Azuma | Co-signal molecules in T-cell activation: historical overview and perspective | |
| JP2021087455A5 (https=) | ||
| JP2024527557A5 (https=) | ||
| CN108610420B (zh) | 抗cd19的人源化抗体以及靶向cd19的免疫效应细胞 | |
| JP2024534847A5 (https=) | ||
| IL277398B1 (en) | Pd-l1 binding affimers, and uses related thereto | |
| JP2025032091A5 (https=) | ||
| JP2020517295A5 (https=) | ||
| IL317912A (en) | A combined chimeric antigen receptor targeting CD19 and CD20 and its applications | |
| JP2022523781A5 (https=) | ||
| CA3176552A1 (en) | Immune activating fc domain binding molecules | |
| WO2021198335A1 (en) | Bispecific antibodies comprising a modified c-terminal crossfab fragment | |
| WO2017030926A1 (en) | Bispecific monovalent diabodies that are capable of binding b7-h3 and cd3, and uses thereof | |
| RU2018109426A (ru) | Химерные антигенные рецепторы со встроенными контролируемыми функциями | |
| CA3180321A1 (en) | Multifunctional molecules that bind to t cell related cancer cells and uses thereof | |
| JP2018527014A5 (https=) | ||
| CN107172880A (zh) | 含有修饰IgG2结构域的引起激动或拮抗特性的修饰抗体及其用途 | |
| JP2021526844A5 (https=) | ||
| JP2021532742A5 (https=) | ||
| JP2022551757A5 (https=) | ||
| JP2024537772A5 (https=) | ||
| JP2023553390A5 (https=) | ||
| JP2023518400A (ja) | 微小ガイダンス及びナビゲーションコントロール（ｍｉｎｉＧＮＣ）抗体様タンパク質、その製造方法及び使用方法 |